Payments to Acquire Property, Plant, and Equipment of Regulus Therapeutics Inc. from 31 Dec 2010 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Regulus Therapeutics Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Mar 2025.
  • Regulus Therapeutics Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $0, a 100% decline year-over-year.
  • Regulus Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $340,000, a 45% decline from 2023.
  • Regulus Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $613,000, a 70% increase from 2022.
  • Regulus Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $361,000, a 44% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Regulus Therapeutics Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $0 -$229,000 -100% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $229,000 +$228,000 +22800% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $1,000 -$101,000 -99% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $102,000 +$49,000 +92% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $53,000 +$53,000 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q1 2020 $0 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q1 2018 $0 -$139,000 -100% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q1 2017 $139,000 -$256,000 -65% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $395,000 +$159,000 +67% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017 2017 Q1
Q1 2015 $236,000 +$161,000 +215% 01 Jan 2015 31 Mar 2015 10-Q 03 May 2016 2016 Q1
Q1 2014 $75,000 -$2,000 -2.6% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015 2015 Q1
Q1 2013 $77,000 -$277,000 -78% 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014 2014 Q1
Q1 2012 $354,000 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1

Regulus Therapeutics Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $340,000 -$273,000 -45% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 $613,000 +$252,000 +70% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $361,000 +$110,000 +44% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $251,000 +$251,000 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023 2022 FY
2020 $0 -$221,000 -100% 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022 2021 FY
2019 $221,000 +$199,000 +905% 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY
2018 $22,000 -$281,000 -93% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2020 2019 FY
2017 $303,000 -$610,000 -67% 01 Jan 2017 31 Dec 2017 10-K 18 Mar 2019 2018 FY
2016 $913,000 -$450,000 -33% 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019 2018 FY
2015 $1,363,000 +$217,000 +19% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2018 2017 FY
2014 $1,146,000 +$346,000 +43% 01 Jan 2014 31 Dec 2014 10-K 03 Mar 2017 2016 FY
2013 $800,000 -$351,000 -30% 01 Jan 2013 31 Dec 2013 10-K 23 Feb 2016 2015 FY
2012 $1,151,000 +$684,000 +146% 01 Jan 2012 31 Dec 2012 10-K 19 Feb 2015 2014 FY
2011 $467,000 -$1,417,000 -75% 01 Jan 2011 31 Dec 2011 10-K 28 Feb 2014 2013 FY
2010 $1,884,000 01 Jan 2010 31 Dec 2010 10-K 19 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.